Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Monash Medical Centre
mi
from
Clayton,
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Monash Medical Centre
mi
from
Clayton,
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
UCLA Clinical AIDS Research and Education (CARE) Center
mi
from
Los Angeles, CA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
UCLA Clinical AIDS Research and Education (CARE) Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Cancer Research Center of Hawaii
mi
from
Honolulu, HI
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Cancer Research Center of Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Boston University Cancer Research Center
mi
from
Boston, MA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Boston University Cancer Research Center
mi
from
Boston, MA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Baylor University Medical Center - Houston
mi
from
Houston, TX
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Baylor University Medical Center - Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Benaroya Research Institute at Virginia Mason Medical Center
mi
from
Seattle, WA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Benaroya Research Institute at Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated:  4/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials
Status: Enrolling
Updated: 4/19/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris
A Randomized Double Blind Multiple Center Placebo Controlled Study Comparing CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® (Clindamycin 1%/Benzoyl Peroxide 5%) Topical Gel in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris
A Randomized Double Blind Multiple Center Placebo Controlled Study Comparing CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® (Clindamycin 1%/Benzoyl Peroxide 5%) Topical Gel in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo, Controlled, Parallel-group Study, Comparing Adapalene/BP Gel, 0.3%/2.5% to EPIDUO® FORTE GEL and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo, Controlled, Parallel-group Study, Comparing Adapalene/BP Gel, 0.3%/2.5% to EPIDUO® FORTE GEL and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
A Single-center, Double-blind, Randomized, Parallel-group Study, Comparing DPSG to a Placebo Control in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
A Single-center, Double-blind, Randomized, Parallel-group Study, Comparing DPSG to a Placebo Control in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Click here to add this to my saved trials
A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris
A Multiple-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to Tazorac® (Tazarotene Cream 0.1%) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris
A Multiple-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to Tazorac® (Tazarotene Cream 0.1%) and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Test Gel, 5% to ACZONE Gel, 5% and Both Active Treatment to a Placebo Control in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Test Gel, 5% to ACZONE Gel, 5% and Both Active Treatment to a Placebo Control in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Efficacy Study in Patients With Acne Vulgaris.
A Multi-center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Adps in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Efficacy Study in Patients With Acne Vulgaris.
A Multi-center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Adps in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Click here to add this to my saved trials
A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel
A Randomized, Controlled Study to Evaluate the Sensitizing Potential of LEO 43204 Gel and Gel Vehicle in Healthy Volunteers Using a Repeat Insult Patch Test Design
Status: Enrolling
Updated:  5/8/2017
TKL research
mi
from
Fair Lawn, NJ
A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel
A Randomized, Controlled Study to Evaluate the Sensitizing Potential of LEO 43204 Gel and Gel Vehicle in Healthy Volunteers Using a Repeat Insult Patch Test Design
Status: Enrolling
Updated: 5/8/2017
TKL research
mi
from
Fair Lawn, NJ
Click here to add this to my saved trials
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
Randomized, Double-Blind, Placebo-Controlled, Parallel-Cohort Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Once-Daily Application of Topical VDA-1102 Ointment for 28 Days in Subjects With Actinic Keratosis
Status: Enrolling
Updated:  5/8/2017
Therapeutics Clinical Research
mi
from
San Diego, CA
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
Randomized, Double-Blind, Placebo-Controlled, Parallel-Cohort Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Once-Daily Application of Topical VDA-1102 Ointment for 28 Days in Subjects With Actinic Keratosis
Status: Enrolling
Updated: 5/8/2017
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluating for Contact Allergies in Patients With Chronic Urticaria
Contact Allergens Causing Chronic Urticaria in a New England-Area Population
Status: Enrolling
Updated:  5/11/2017
Tufts Medical Center, Department of Dermatology
mi
from
Boston, MA
Evaluating for Contact Allergies in Patients With Chronic Urticaria
Contact Allergens Causing Chronic Urticaria in a New England-Area Population
Status: Enrolling
Updated: 5/11/2017
Tufts Medical Center, Department of Dermatology
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Johnson Dermatology
mi
from
Fort Smith, AR
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Johnson Dermatology
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
California Dermatology and Clinical Research Institute
mi
from
Encinitas, CA
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
California Dermatology and Clinical Research Institute
mi
from
Encinitas, CA
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Silverberg MD Inc.
mi
from
Newport Beach, CA
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Silverberg MD Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
BayState Clinical Trials
mi
from
Watertown, MA
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
BayState Clinical Trials
mi
from
Watertown, MA
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Hamzavi Dermatology Clinical Trials
mi
from
Fort Gratiot, MI
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Hamzavi Dermatology Clinical Trials
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Austin Institute for Clinical Research Inc.
mi
from
Austin, TX
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Austin Institute for Clinical Research Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
DermResearch, Inc.
mi
from
Austin, TX
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Northwest Arkansas Clinical Trials Center, PLLC
mi
from
Rogers, AR
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Northwest Arkansas Clinical Trials Center, PLLC
mi
from
Rogers, AR
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Metro Boston Clinical Partners, LLC
mi
from
Needham, MA
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Metro Boston Clinical Partners, LLC
mi
from
Needham, MA
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Minnesota Clinical Study Center
mi
from
Fridley, MN
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Dermatology Consulting Services
mi
from
High Point, NC
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Oregon Medical Research Center, PC
mi
from
Portland, OR
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Oregon Medical Research Center, PC
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
Dermatology Research Center
mi
from
Salt Lake City, UT
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
Dermatology Research Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/15/2017
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/15/2017
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Dallas, TX
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Rogers, AR
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Rogers, AR
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Fremont, CA
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Fremont, CA
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Lomita, CA
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Miami, FL
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Arlington Heights, IL
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Elwood, IN
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Elwood, IN
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Owensboro, KY
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Owensboro, KY
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Beverly, MA
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Beverly, MA
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Haverhill, MA
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Haverhill, MA
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Fort Gratiot, MI
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated:  5/16/2017
Clinical Research Facility
mi
from
Newington, NH
A Phase 2 Trial of East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
A Randomized, Double-blind, Parallel-group, Multicenter, Placebo-controlled Phase 2 Dose-ranging Trial of the Efficacy and Safety of a New Botanical Drug Product Containing East Indian Sandalwood Oil in the Treatment of Common Warts (Verruca Vulgaris)
Status: Enrolling
Updated: 5/16/2017
Clinical Research Facility
mi
from
Newington, NH
Click here to add this to my saved trials